Obstacles and future of gene therapy for hemophilia.
Valder R ArrudaBen J Samelson-JonesPublished in: Expert opinion on orphan drugs (2015)
Our opinion is that these obstacles can be overcome with current approaches, and AAV-based gene therapy for HB will likely translate into future clinical care. Innovative approaches are, however, likely needed to solve the current problems obstructing HA gene therapy.